Monday！！！
$Geron(GERN.US$ Geron (GERN) said Friday it received approval from the US Food and Drug Administration for its drug Rytelo as a treatment of adult patients with lower-risk myelodysplastic syndrome, a type of leukemia.
Disclaimer: Community is offered by Moomoo Technologies Inc. and is for educational purposes only.
Read more
Comment
Sign in to post a comment
